We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.40 | -0.89% | 44.70 | 44.50 | 46.00 | 45.50 | 44.55 | 44.75 | 3,371,487 | 16:35:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -3.27 | 128.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/1/2020 23:14 | As we have been discussing for some time, the existing deals having been made and as the management puts it " further active discussions" should result in much higher share price, with the company building a very strong momentum in their diagnostics business and attracting a lot of commercial interest in their AVA6000.Using chart break out etc is not relevant for a company like this.Once a Biotech company like Avacta attracts and secures license deals with majors like LG Chem, Daewoong and ADC Therapeutics all with targeted milestone payments and fully funded R&D and marketing, you will find other majors joining or investing.This is not about MAV, this is about a pipe line, clinical trials and License deals which will push this company's valuation up in the premier league.The trick is not to sell to early.Read the CEO's feedback from JPM Biotech conference. | nordic1958 | |
29/1/2020 22:45 | Said yesterday it looked like a 'breakaway gap' higher (i.e. gap wouldn't be filled it represented a continuation pattern) Today stormed through the 200 day Moving Average I really don't see what stops it 'melting up' now ? So much deal flow in the pipeline and the Market Cap won't reflect real value of historic 'Invested Capital' until we get to market cap of £100m+ odd | the stigologist | |
29/1/2020 22:39 | 14 projects including 4 with 10 of the largest Pharma companies in the World | the stigologist | |
29/1/2020 19:08 | 6x tax free from 2018 placing would be very nice, but please not till 2021! | bscuit | |
29/1/2020 17:27 | Good to see nice buying interest all afternoon and good prints after hours | nordic1958 | |
29/1/2020 16:35 | "If we see the same improvement in humans using Pro-Doxorubicin as we have seen in animals there is huge commercial opportunity, especially as the safety profile of fourteen other drugs might potentially be enhanced through Tufts technology," he said in October.He also noted in January 2020 that cell and gene therapies are attracting "intense clinical and commercial interest", with some major acquisitions of early-stage stem cell companies in the second half of last year.Of the Daewoong joint venture he said: "Our vision is to combine our platforms to create the next generation of cell therapies, for which the potential is huge."Note the language used " intense clinical and commercial interest " Create the next generation of cell therapies, for which the potential is huge "You rarely see that sort of confident language being used by a CEO, but watch the videos having been made the company and on their website and see what spectacular results having been achieved pre clinical, it certainly looks to be a very interesting 2020 with a complete re valuation of the company and with more commercial deals to be announced. | nordic1958 | |
29/1/2020 16:16 | Keep calm.. there will inevitably be profit taking but looking to treble from here.. | losses | |
29/1/2020 16:09 | This doesn't require any ramping. It can easily go up 10x or even 100x by dint of the sector it operates in. e.g. LG Chem signed a $300m deal There are plenty of other Large Pharmas I understand US Pharma sector make $70bn in profit a year ! I Platform Technology which works in this area is going to get licensed or bought out for big money | the stigologist | |
29/1/2020 16:03 | Dave4545 You only hold BAGR and look what’s happened there. I pity you as an individual actually. You never see the positive in anything. If you really did buy last week then you’ve probably made about £100 profit, if that. You’ll need a hell of a lot of trades this year to claw back your massive loses in BAGR won’t you! | intheknow69 | |
29/1/2020 15:43 | US oncology raising money at 40x, AVCT trading at less than 1 | nordic1958 | |
29/1/2020 15:43 | You've probably already sold out, your longest term hold are about 18 hours max I feel sorry for anybody taken in by your garbage 3 stocks alone you were pumping heavily have or are going to be delisted. I'll continue to use you as a good indicator to take my profits | dave4545 | |
29/1/2020 15:38 | Dave4545 Your right about one thing my friend.....I’m a good indicator. I have the heads up about GEO before it soured 160% yesterday. That’s what you call a profit. Just like here.....seriously undervalued and ripe for a take out by one of the big Pharmas. | intheknow69 | |
29/1/2020 15:36 | Most amusing these predictions you make,good luck. 30 by Friday | nordic1958 | |
29/1/2020 15:32 | Moron dumping big time now pressure is on and share price will sink back | iamgreat1 | |
29/1/2020 15:20 | Miton's holding was acquired through their participation in the placing at 15p.Their merger with Premier Asset management have cause forced rotation and redemption.Let us see over the next week!Buyers are lining up and by Friday we should be in a new trading range.Good luck if you are taking profit at these levels, as the company has indicated, positive news flow going forward.The Koreans wants a more active role going forward and other majors are looking at this. | nordic1958 | |
29/1/2020 15:10 | He's a good indicator of when to take profits or take a big slice and bank a free ride. I'm certain this will be over 30p at some point but I took a lot of profit ..69 is a very good indicator I'll put that money to work elsewhere | dave4545 | |
29/1/2020 15:09 | Miton RNS relates to 27th You are allowed to not inform for every 1% if it's part of one trade so I'd guess they are done selling which is why the stock went up as it has | the stigologist | |
29/1/2020 15:08 | What goes up must come down. | jimbob999 | |
29/1/2020 15:08 | Holds 4.87% vs 5.3%I think you will find that holding is going north again and fast.You will be lucky to get stock at 30 by FridayUS is coming, they are not stupid, read-across valuation makes Avacta stand out as one of the cheapest in the global sector.Watch the shareholder register, buyers are coming in size! | nordic1958 | |
29/1/2020 15:02 | RNS.....MITON almost out! | intheknow69 | |
29/1/2020 14:31 | Dave4545 Post a screenshot.......the | intheknow69 | |
29/1/2020 14:28 | 14/1/20 Trades 14/15 2 x 25k at 17.773p 15/1/20 Trades 4 and 5 2 x 25k at 17.9 | dave4545 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions